Individuals dealing with chronic back pain in Guro and surrounding areas can now access regenerative stem cell therapy ...

Findings from an interim analysis showed CELZ-201-DDT statistically significantly reduced pain and improved mobility in patients with chronic lower back pain. The Food and Drug Administration (FDA) ...

How does spinal decompression work, and why is it considered a gentle option for disc-related pain? LOCUST , NC, UNITED ...

Disc-related back pain may one day meet its therapeutic match: gene therapy delivered by naturally derived nanocarriers that, a new study shows, repairs damaged discs in the spine and lowers pain ...

Around four years ago, Hannah Polach, 42, began experiencing numbness and tingling in her arms that would wake her from a ...

It feels like back pain comes for many of us at some point in our lives, and it’s tricky to treat. A new gene therapy, which repairs damaged discs and reduces pain, has shown promise in mouse tests.

Phase I/II data of IDCT (rebonuputemcel), a cell therapy in development for chronic and progressive lumbar degenerative disc disease and one that has both regenerative medicine advanced therapy and ...

BioRestorative Therapies (NASDAQ:BRTX) stock rose 8% early Monday after the company announced it had presented encouraging data from a Phase 2 study of its therapy candidate BRTX-100 in the treatment ...

FibroBiologics is pursuing a development program for FSdC spheroids with the goal of advancing to clinical trials. The data includes comprehensive preclinical pharmacology and efficacy assessments ...

Intervertebral disk tissue was obtained from 35 patients undergoing surgery for chronic degenerative disease (n = 25) or an acutely herniated disk (n = 12). Of note, 48% of patients with degenerative ...

M+ cash runway to 2029, bitopertin FDA NDA/accelerated approval catalyst, and DISC-0974 myelofibrosis data—read now.